In summary, the present study demonstrates that EGFR/HER1 is suppressed and negatively associated with estradiol and ER, whereas HER3, and potentially HER2 and HER4, are elevated and positively associated with estradiol in HER2 non-amplified breast tumours from postmenopausal women. Here, ERBB4 is linked to breast neoplasm.